FVC/DLCO identifies pulmonary hypertension and predicts 5-year all-cause mortality in patients with COPD

[1] Christenson SA(2015)Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 385 117-171

[2] Smith BM(2022)Chronic obstructive pulmonary disease Lancet 399 2227-2242

[3] Bafadhel M(2013)Chronic obstructive pulmonary disease and comorbidities Lancet Respir Med 1 73-83

[4] Putcha N(2012)COPD and associated comorbidities: a review of current diagnosis and treatment Postgrad Med 124 225-240

[5] Decramer M(2020)Updated perspectives on pulmonary hypertension in COPD Int J Chron Obstruct Pulmon Dis 15 1315-1324

[6] Janssens W(2001)“Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease Am J Respir Crit Care Med 164 219-224

[7] Carlin BW(2005)Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation Chest 127 1531-1536

[8] Blanco I(2002)Hemodynamic characterization of patients with severe emphysema Am J Respir Crit Care Med 166 314-322

[9] Tura-Ceide O(2021)Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis Eur Respir Rev 30 200321-164

[10] Peinado VI(1999)Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 158-1882

[1] Christenson SA(2015)Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 385 117-171

[2] Smith BM(2022)Chronic obstructive pulmonary disease Lancet 399 2227-2242

[3] Bafadhel M(2013)Chronic obstructive pulmonary disease and comorbidities Lancet Respir Med 1 73-83

[4] Putcha N(2012)COPD and associated comorbidities: a review of current diagnosis and treatment Postgrad Med 124 225-240

[5] Decramer M(2020)Updated perspectives on pulmonary hypertension in COPD Int J Chron Obstruct Pulmon Dis 15 1315-1324

[6] Janssens W(2001)“Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease Am J Respir Crit Care Med 164 219-224

[7] Carlin BW(2005)Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation Chest 127 1531-1536

[8] Blanco I(2002)Hemodynamic characterization of patients with severe emphysema Am J Respir Crit Care Med 166 314-322

[9] Tura-Ceide O(2021)Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis Eur Respir Rev 30 200321-164

[10] Peinado VI(1999)Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 158-1882